{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:02:08Z","timestamp":1790143328222,"version":"4.0.1"},"reference-count":58,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CNRS"},{"DOI":"10.13039\/501100004718","name":"Toulouse University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004718","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Infinity"},{"name":"the D\u00e9fi Cl\u00e9 Cell Based Biotherapies Occitanie"},{"name":"the association \u201cDes \u00e9toiles dans la mer, vaincre le glioblastome\u201d"},{"name":"the foundation \u201cFONROGA\u201d"},{"name":"the association \u201cEva pour la vie\u201d"},{"name":"the association \u201cRapha\u00ebl Coeur Chocolat\u201d"},{"name":"the association \u201c111 Des Arts, Toulouse\u201d"},{"DOI":"10.13039\/501100004099","name":"the Ligue contre le cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the foundation \u201cFlavien\u201d"},{"name":"the federation \u201cGrandir sans cancer\u201d"},{"name":"the \u201cAssociation pour la Recherche sur les Tumeurs C\u00e9r\u00e9brales\u201d"},{"name":"the Occitanie Region"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Glioblastoma (GB) is a highly aggressive brain tumor with a very poor prognosis. Treatment usually consists of surgery, followed by radiotherapy and chemotherapy, but the prognosis remains poor due to its resistance to therapies and a high recurrence rate. Multiple studies have reported the presence of human cytomegalovirus (HCMV) proteins and\/or nucleic acids in GB tissues, suggesting its possible implication. These findings have led to the hypothesis that HCMV may contribute to tumor progression, immune evasion, angiogenesis, and resistance to therapy. Clinical trials using anti-HCMV therapies have shown promising preliminary results, indicating a potential therapeutic benefit. This review aims to provide a comprehensive overview of the current evidence linking HCMV to GB and the therapeutic implications. A deeper understanding of this complex interaction could unveil novel strategies for GB treatment.<\/jats:p>","DOI":"10.3390\/pathogens14121291","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:00:26Z","timestamp":1765882826000},"page":"1291","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting Human Cytomegalovirus as a Novel Approach for Glioblastoma Treatment"],"prefix":"10.3390","volume":"14","author":[{"given":"Thelma","family":"Flores","sequence":"first","affiliation":[{"name":"Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Universit\u00e9 de Toulouse, INSERM, CNRS, UT, H\u00f4pital Purpan-BP 3028, 1 Place du Dr Baylac, 31024 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00efse","family":"Delpierre","sequence":"additional","affiliation":[{"name":"Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Universit\u00e9 de Toulouse, INSERM, CNRS, UT, H\u00f4pital Purpan-BP 3028, 1 Place du Dr Baylac, 31024 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislain","family":"Male","sequence":"additional","affiliation":[{"name":"Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Universit\u00e9 de Toulouse, INSERM, CNRS, UT, H\u00f4pital Purpan-BP 3028, 1 Place du Dr Baylac, 31024 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-437X","authenticated-orcid":false,"given":"Claire","family":"Gourin","sequence":"additional","affiliation":[{"name":"INSERM, RESINFIT, U1092, Universit\u00e9 de Limoges, 2 rue du Dr Marcland, 87025 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2635-0773","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Hantz","sequence":"additional","affiliation":[{"name":"INSERM, RESINFIT, U1092, Universit\u00e9 de Limoges, 2 rue du Dr Marcland, 87025 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Damour","sequence":"additional","affiliation":[{"name":"INSERM, RESINFIT, U1092, Universit\u00e9 de Limoges, 2 rue du Dr Marcland, 87025 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1237-1936","authenticated-orcid":false,"given":"Ga\u00ebtan","family":"Ligat","sequence":"additional","affiliation":[{"name":"Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Universit\u00e9 de Toulouse, INSERM, CNRS, UT, H\u00f4pital Purpan-BP 3028, 1 Place du Dr Baylac, 31024 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.annpat.2021.11.005","article-title":"La classification de l\u2019OMS 2021 des tumeurs du syst\u00e8me nerveux central","volume":"42","author":"Appay","year":"2022","journal-title":"Ann. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The Somatic Genomic Landscape of Glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and Molecular Prognostic Review of Glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) Guideline on the Diagnosis and Treatment of Adult Astrocytic and Oligodendroglial Gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/femsre\/fuy004","article-title":"The Human Cytomegalovirus Terminase Complex as an Antiviral Target: A Close-up View","volume":"42","author":"Ligat","year":"2018","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1684\/vir.2024.1063","article-title":"Challenges and advances in the management of HCMV infections","volume":"28","author":"Gourin","year":"2024","journal-title":"Virologie"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1099\/vir.0.81891-0","article-title":"Latency and Reactivation of Human Cytomegalovirus","volume":"87","author":"Sinclair","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bpobgyn.2016.10.005","article-title":"Fetal Cytomegalovirus Infection","volume":"38","author":"Ville","year":"2017","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1470-2045(25)00403-6","article-title":"Carcinogenicity of Hepatitis D Virus, Human Cytomegalovirus, and Merkel Cell Polyomavirus","volume":"26","author":"Karagas","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood-2016-07-723148","article-title":"In Utero Cytomegalovirus Infection and Development of Childhood Acute Lymphoblastic Leukemia","volume":"129","author":"Francis","year":"2017","journal-title":"Blood"},{"key":"ref_12","first-page":"3347","article-title":"Human Cytomegalovirus Infection and Expression in Human Malignant Glioma","volume":"62","author":"Cobbs","year":"2002","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"20240403","DOI":"10.1098\/rstb.2024.0403","article-title":"Does Human Cytomegalovirus Provide a Novel Therapeutic Target for Patients with Glioblastoma?","volume":"380","author":"Pantalone","year":"2025","journal-title":"Philos. Trans. R. Soc. B"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Stragliotto, G., Pantalone, M.R., Rahbar, A., and S\u00f6derberg-Naucl\u00e9r, C. (2020). Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101471"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.18632\/oncotarget.1787","article-title":"HCMV Glycoprotein B Is Expressed in Primary Glioblastomas and Enhances Growth and Invasiveness via PDGFR-Alpha Activation","volume":"5","author":"Cobbs","year":"2014","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1158\/0008-5472.CAN-14-3307","article-title":"Cytomegalovirus Immediate Early Proteins Promote Stemness Properties in Glioblastoma","volume":"75","author":"Soroceanu","year":"2015","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/glia.20179","article-title":"Downregulation of GFAP, TSP-1, and P53 in Human Glioblastoma Cell Line, U373MG, by IE1 Protein from Human Cytomegalovirus","volume":"51","author":"Lee","year":"2005","journal-title":"Glia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1158\/0008-5472.CAN-07-2291","article-title":"Modulation of Oncogenic Phenotype in Human Glioma Cells by Cytomegalovirus IE1\u2013Mediated Mitogenicity","volume":"68","author":"Cobbs","year":"2008","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1128\/JVI.00304-09","article-title":"Human Cytomegalovirus IE1-72 Protein Interacts with P53 and Inhibits P53-Dependent Transactivation by a Mechanism Different from That of IE2-86 Protein","volume":"83","author":"Hwang","year":"2009","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35052535","article-title":"Gliomagenesis: Genetic Alterations and Mouse Models","volume":"2","author":"Holland","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2021.05.005","article-title":"Cytomegalovirus Infection of Glioblastoma Cells Leads to NF-\u03baB Dependent Upregulation of the c-MET Oncogenic Tyrosine Kinase","volume":"513","author":"Krenzlin","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Diggins, N.L., Skalsky, R.L., and Hancock, M.H. (2021). Regulation of Latency and Reactivation by Human Cytomegalovirus miRNAs. Pathogens, 10.","DOI":"10.3390\/pathogens10020200"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44705","DOI":"10.1038\/srep44705","article-title":"HCMV-Encoded miR-UL112-3p Promotes Glioblastoma Progression via Tumour Suppressor Candidate 3","volume":"7","author":"Liang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm.2158","article-title":"A Genome-Wide RNA Interference Screen Reveals an Essential CREB3L2-ATF5-MCL1 Survival Pathway in Malignant Glioma with Therapeutic Implications","volume":"16","author":"Sheng","year":"2010","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1021\/acschemneuro.1c00576","article-title":"Human Cytomegalovirus Infection Activates Glioma Activating Transcription Factor 5 via microRNA in a Stress-Induced Manner","volume":"12","author":"Hu","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3892\/ol.2014.2264","article-title":"Human Cytomegalovirus Inhibits Apoptosis by Regulating the Activating Transcription Factor 5 Signaling Pathway in Human Malignant Glioma Cells","volume":"8","author":"Wang","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13068","DOI":"10.1073\/pnas.0604433103","article-title":"Human Cytomegalovirus-Encoded Chemokine Receptor US28 Promotes Tumorigenesis","volume":"103","author":"Maussang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-11-0744","article-title":"Human Cytomegalovirus US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype","volume":"71","author":"Soroceanu","year":"2011","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ra58","DOI":"10.1126\/scisignal.2001180","article-title":"HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6\u2013STAT3 Axis","volume":"3","author":"Slinger","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67966","DOI":"10.18632\/oncotarget.11817","article-title":"Human Cytomegalovirus Encoded Chemokine Receptor US28 Activates the HIF-1\u03b1\/PKM2 Axis in Glioblastoma Cells","volume":"7","author":"Siderius","year":"2016","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JVI.76.3.1285-1292.2002","article-title":"Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10","volume":"76","author":"Spencer","year":"2002","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/djp031","article-title":"Activation of Telomerase by Human Cytomegalovirus","volume":"101","author":"Liu","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Harrison, M.A.A., Hochreiner, E.M., Benjamin, B.P., Lawler, S.E., and Zwezdaryk, K.J. (2022). Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment. Viruses, 14.","DOI":"10.3390\/v14010103"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41698-024-00709-4","article-title":"Clinical Implications of Cytomegalovirus in Glioblastoma Progression and Therapy","volume":"8","author":"Mercado","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1182\/blood.V99.8.2913","article-title":"Human Cytomegalovirus Inhibits Maturation and Impairs Function of Monocyte-Derived Dendritic Cells","volume":"99","author":"Moutaftsi","year":"2002","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shen, Y., Zhang, L., Xue, X., and Feng, S. (2025). Molecular Mechanisms and Targets Underlying Immune Evasion by Human Cytomegalovirus. J. Microbiol. Immunol. Infect., in press.","DOI":"10.1016\/j.jmii.2025.06.005"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cox, M., Kartikasari, A.E.R., Gorry, P.R., Flanagan, K.L., and Plebanski, M. (2021). Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040351"},{"key":"ref_38","first-page":"2637","article-title":"Human Cytomegalovirus Infection Enhances Invasiveness and Migration of Glioblastoma Cells by Epithelial-to-Mesenchymal Transition","volume":"13","author":"Zhu","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5","article-title":"Expression of TGF-\u03b2 Isoforms, TGF-\u03b2 Receptors, and SMAD Molecules at Different Stages of Human Glioma","volume":"89","author":"Kjellman","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/s41388-023-02709-3","article-title":"EZH2-Myc Driven Glioblastoma Elicited by Cytomegalovirus Infection of Human Astrocytes","volume":"42","author":"Pasquereau","year":"2023","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.179143","article-title":"Oncogenic Transformation of Human Embryo Lung Cells by Human Cytomegalovirus","volume":"192","author":"Geder","year":"1976","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","article-title":"The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells","volume":"30","author":"Kumar","year":"2018","journal-title":"eBioMedicine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41417-024-00767-7","article-title":"Generation of Glioblastoma in Mice Engrafted with Human Cytomegalovirus-Infected Astrocytes","volume":"31","author":"Guyon","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2423983","DOI":"10.1080\/2162402X.2024.2423983","article-title":"FGL2172-220 Peptides Improve the Antitumor Effect of HCMV-IE1mut Vaccine against Glioblastoma by Modulating Immunosuppressive Cells in the Tumor Microenvironment","volume":"13","author":"Wang","year":"2024","journal-title":"OncoImmunology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1038\/s41388-018-0255-7","article-title":"The Constitutive Activity of the Virally Encoded Chemokine Receptor US28 Accelerates Glioblastoma Growth","volume":"37","author":"Heukers","year":"2018","journal-title":"Oncogene"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Dong, X.-D., Li, Y., Li, Y., Sun, C., Liu, S.-X., Duan, H., Cui, R., Zhong, Q., Mou, Y.-G., and Wen, L. (2023). EphA2 Is a Functional Entry Receptor for HCMV Infection of Glioblastoma Cells. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011304"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Song, J., Ma, Q., Hu, M., Qian, D., Wang, B., and He, N. (2018). The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells. Molecules, 23.","DOI":"10.3390\/molecules23123259"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"N17","DOI":"10.1227\/01.neu.0000445337.42703.0b","article-title":"VIGAS and Beyond: The Impact of HCMV-Infection and Its Treatment in Glioblastoma","volume":"74","author":"Ottenhausen","year":"2014","journal-title":"Neurosurgery"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/MCB.05639-11","article-title":"Translational Control of TOP2A Influences Doxorubicin Efficacy","volume":"31","author":"Srikantan","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.bbrc.2015.06.061","article-title":"MicroRNA-139 Suppresses Proliferation in Luminal Type Breast Cancer Cells by Targeting Topoisomerase II Alpha","volume":"463","author":"Hua","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106289","DOI":"10.1016\/j.antiviral.2025.106289","article-title":"Deciphering Letermovir\u2019s Mode of Action and Resistance Mutation Effects","volume":"244","author":"Gourin","year":"2025","journal-title":"Antivir. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1038\/s41598-017-09469-7","article-title":"Identification of a Short Sequence in the HCMV Terminase pUL56 Essential for Interaction with pUL89 Subunit","volume":"7","author":"Ligat","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ligat, G., Couvreux, A., Cazal, R., Alain, S., and Hantz, S. (2019). Highlighting of a LAGLIDADG and a Zing Finger Motifs Located in the pUL56 Sequence Crucial for HCMV Replication. Viruses, 11.","DOI":"10.3390\/v11121093"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Gourin, C., Lef\u00e8vre, C., Flores, T., Couvreux, A., Alain, S., Ligat, G., and Hantz, S. (2025). Key Domains Involved in the Interaction and Assembly of the HCMV Terminase Complex. Sci. Rep.","DOI":"10.1038\/s41598-025-28915-5"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Muller, C., Alain, S., Gourin, C., Baumert, T.F., Ligat, G., and Hantz, S. (2021). New Insights into Human Cytomegalovirus pUL52 Structure. Viruses, 13.","DOI":"10.3390\/v13081638"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ligat, G., Da Re, S., Alain, S., and Hantz, S. (2018). Identification of Amino Acids Essential for Viral Replication in the HCMV Helicase-Primase Complex. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02483"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2146\/ajhp090424","article-title":"Drug Interactions and Toxicities Associated with the Antiviral Management of Cytomegalovirus Infection","volume":"67","author":"Jacobsen","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"106259","DOI":"10.1016\/j.antiviral.2025.106259","article-title":"First Evidence of Efficacy of Peptides Targeting the pUL56-pUL89 Interaction Domain of the Human Cytomegalovirus Terminase Complex","volume":"242","author":"Mafi","year":"2025","journal-title":"Antivir. Res."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/12\/1291\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:21:57Z","timestamp":1766035317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/12\/1291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["pathogens14121291"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14121291","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]}}}